Neurology, Vol 45, Issue 6 1138-1143, Copyright © 1995 by American Academy of Neurology

ARTICLES

Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease [published erratum appears in Neurology 1995 Jul;45(7):1420]

JM Gorell, RJ Ordidge, GG Brown, JC Deniau, NM Buderer and JA Helpern
Department of Neurology, Henry Ford Hospital and Health Sciences Center, Detroit, MI 48202, USA.

Elevated iron levels in the substantia nigra (SN) of the brain in Parkinson's disease (PD) may mediate lipid peroxidative reactions, promoting SN neuronal death. To assess SN iron accumulation in living PD patients and its relation to motor performance, we measured, in 13 nondemented PD patients and 10 normal control subjects, simple reaction time (SRT) and simple movement time (SMT), followed by head MRI in a 3- tesla system. We measured T2 and T2* in the right and left SN of all subjects and calculated R2', the relaxation rate due to local magnetic field in-homogeneities, from these values. Asymmetries of 1/T2 (R2), 1/T2* (R2*), or R2' versus asymmetries of SRT and SMT were assessed in eight PD subjects who had not taken anti-PD medication(s) for 12 hours. The average of right and left SN values for R2 was lower, and R2* and R2' were higher, in PD patients than in controls (R2, p = 0.046; R2*, p = 0.001; R2', p < 0.001). R2' best predicted group differences. The asymmetry of SRT performance was highly correlated with asymmetries of SN R2* (0.91; p = 0.001) and R2' (0.72; p = 0.03). These results strongly suggest that the increases in iron levels seen postmortem in the SN in PD are reflected in increased iron-related MRI contrast at 3 tesla in living PD patients. Correlations with motor performance in PD suggest that the clinical severity of PD may be related to SN iron accumulation.

This article has been cited by other articles:

				W. R. W. Martin, M. Wieler, and M. Gee Midbrain iron content in early Parkinson disease: A potential biomarker of disease status Neurology, April 15, 2008; 70(16_Part_2): 1411 - 1417. [Abstract] [Full Text] [PDF]

				J. P Bressler, L. Olivi, J. H. Cheong, Y. Kim, A. Maerten, and D. Bannon Metal transporters in intestine and brain: their involvement in metal-associated neurotoxicities Human and Experimental Toxicology, March 1, 2007; 26(3): 221 - 229. [Abstract] [PDF]

				L. Minati, M. Grisoli, F. Carella, T. De Simone, M.G. Bruzzone, and M. Savoiardo Imaging Degeneration of the Substantia Nigra in Parkinson Disease with Inversion-Recovery MR Imaging AJNR Am. J. Neuroradiol., February 1, 2007; 28(2): 309 - 313. [Abstract] [Full Text] [PDF]

				K J H Robson, A T Merryweather-Clarke, E Cadet, V Viprakasit, M G Zaahl, J J Pointon, D J Weatherall, and J Rochette Recent advances in understanding haemochromatosis: a transition state J. Med. Genet., October 1, 2004; 41(10): 721 - 730. [Abstract] [Full Text] [PDF]

				D J Costello, S L Walsh, H J Harrington, and C H Walsh Concurrent hereditary haemochromatosis and idiopathic Parkinson's disease: a case report series J. Neurol. Neurosurg. Psychiatry, April 1, 2004; 75(4): 631 - 633. [Abstract] [Full Text] [PDF]

				M. P. MATTSON Metal-Catalyzed Disruption of Membrane Protein and Lipid Signaling in the Pathogenesis of Neurodegenerative Disorders Ann. N.Y. Acad. Sci., March 1, 2004; 1012(1): 37 - 50. [Abstract] [Full Text] [PDF]

				M. E. GOTZ, K. DOUBLE, M. GERLACH, M. B. H. YOUDIM, and P. RIEDERERE The Relevance of Iron in the Pathogenesis of Parkinson's Disease Ann. N.Y. Acad. Sci., March 1, 2004; 1012(1): 193 - 208. [Abstract] [Full Text] [PDF]

				H. Oikawa, M. Sasaki, Y. Tamakawa, S. Ehara, and K. Tohyama The Substantia Nigra in Parkinson Disease: Proton Density-Weighted Spin-Echo and Fast Short Inversion Time Inversion-Recovery MR Findings AJNR Am. J. Neuroradiol., November 1, 2002; 23(10): 1747 - 1756. [Abstract] [Full Text] [PDF]

				C. S. Georgiades, R. Itoh, X. Golay, P. C. M. van Zijl, and E. R. Melhem MR Imaging of the Human Brain at 1.5 T: Regional Variations in Transverse Relaxation Rates in the Cerebral Cortex AJNR Am. J. Neuroradiol., October 1, 2001; 22(9): 1732 - 1737. [Abstract] [Full Text] [PDF]

				Y.-Y. Hsu, A.-T. Du, N. Schuff, and M. W. Weiner Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy in Dementias J Geriatr Psychiatry Neurol, September 1, 2001; 14(3): 145 - 166. [Abstract] [PDF]

				J. M. Graham, M. N. J. Paley, R. A. Grunewald, N. Hoggard, and P. D. Griffiths Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence Brain, December 1, 2000; 123(12): 2423 - 2431. [Abstract] [Full Text] [PDF]

				M. Hutchinson and U. Raff Structural Changes of the Substantia Nigra in Parkinson's Disease as Revealed by MR Imaging AJNR Am. J. Neuroradiol., April 1, 2000; 21(4): 697 - 701. [Abstract] [Full Text]

				M. Hutchinson and U. Raff Parkinson's disease: a novel MRI method for determining structural changes in the substantia nigra J. Neurol. Neurosurg. Psychiatry, December 1, 1999; 67(6): 815 - 818. [Abstract] [Full Text] [PDF]

				K. N. Prasad, W. C. Cole, and B. Kumar Multiple Antioxidants in the Prevention and Treatment of Parkinson's Disease J. Am. Coll. Nutr., October 1, 1999; 18(5): 413 - 423. [Abstract] [Full Text] [PDF]

				M. Adachi, T. Hosoya, T. Haku, K. Yamaguchi, and T. Kawanami Evaluation of the Substantia Nigra in Patients with Parkinsonian Syndrome Accomplished Using MultishotDiffusion-Weighted MR Imaging AJNR Am. J. Neuroradiol., September 1, 1999; 20(8): 1500 - 1506. [Abstract] [Full Text]

				N. Gelman, J. M. Gorell, P. B. Barker, R. M. Savage, E. M. Spickler, J. P. Windham, and R. A. Knight MR Imaging of Human Brain at 3.0 T: Preliminary Report on Transverse Relaxation Rates and Relation to Estimated Iron Content Radiology, March 1, 1999; 210(3): 759 - 767. [Abstract] [Full Text]